Recently, Shanghai Haishun new pharmaceutical packaging materials Co., Ltd. (hereinafter referred to as Haishun new materials) has strategically invested in Shijiazhuang Zhonghui pharmaceutical packaging Co., Ltd. (hereinafter referred to as Zhonghui pharmaceutical packaging Co., Ltd.). In this cooperation, the equity structure of Zhonghui pharmaceutical packaging Co., Ltd. has changed, becoming a holding subsidiary of Haishun new materials.
general trend
To improve the overall comprehensive strength of China's pharmaceutical packaging industry, it is imperative for enterprises in the industry to integrate and combine to form scale effect.
According to different materials, drug packaging materials are mainly divided into five categories: plastic, glass, rubber, metal and composite materials. Drug packaging materials are involved in the whole process of drug production, circulation and use, which directly affects the quality of drugs and plays an important role in the whole pharmaceutical industry.
With the continuous development of economy and technology, the improvement of packaging industry level is obvious to all. As a special commodity, the packaging materials of pharmaceutical products are constantly updated.
Looking at the international market, in recent years, the world pharmaceutical packaging industry has made new breakthroughs in development through strong alliance, transnational cooperation and other measures. New materials, new processes, new technologies and new products of pharmaceutical packaging have been emerging, and the degree of standardization has been improving, forming a high-speed and vigorous industry.
China's pharmaceutical packaging industry started late, and only in the 1990s did it have a systematic national standard and industry standard. Since 2000, the pharmaceutical packaging industry has entered a period of rapid development. After more than ten years of development, the innovation ability of the pharmaceutical packaging industry in China has been continuously enhanced, but there is still a certain gap compared with developed countries. According to some data, at present, there are thousands of enterprises of different scales in the field of pharmaceutical packaging in China, with serious homogenization of middle and low-end products and poor ability of independent innovation.
"There are still small, scattered and disordered phenomena in the domestic drug packaging material industry." Fan Jumin, general manager of Zhonghui pharmaceutical packaging Co., Ltd., thinks that the customized characteristics of domestic pharmaceutical packaging material enterprises are outstanding, but the degree of standardization and specialization is very low. "Some small pharmaceutical packaging material enterprises only supply for one pharmaceutical enterprise, and some pharmaceutical enterprises only build their own pharmaceutical packaging material factories for their own service, so there is still a lot of room for improvement of domestic pharmaceutical packaging material industry."
The lack of a healthy and stable market environment, at the same time, the investment is very large, the cost is very high, and the profit of the domestic drug packaging industry is very small. "It is very difficult for an enterprise to achieve development only by its own rolling, so it is necessary to introduce strategic investors to make up for the lack of funds." Fan Jumin said frankly that this is one of the reasons why China and foreign exchange seek cooperation.
To make up for the short board of innovation and development and improve the level of domestic pharmaceutical packaging industry is also the driving force for Zhonghui pharmaceutical packaging to vigorously promote technology and product research and development since it embarked on the road of independent development. "The cooperation with Haishun New Material Co., Ltd. is also the contribution of both sides to the development of the industry, industrialization and international layout." Fan Jumin said.
